Cannabinoid Research & Product Design
In strategic association with Sheen Biotech Pvt. Ltd., conducting research and early-stage product design involving CBD, CBG, and THCA under strict regulatory standards.
The Endocannabinoid Science & AYUSH Fusion
Cannabidiol (CBD) is a non-intoxicating cannabinoid found in the Cannabis sativa plant. Its biological interaction with CB1, CB2, and TRPV1 receptors throughout the human endocannabinoid system has generated immense scientific interest across oncology supportive care, sleep architecture, and neurological wellbeing.
Our joint research programme with Sheen Biotech Pvt. Ltd. combines botanical science, cannabinoid profiling, molecular formulation approaches, pharmaceutical dosage design, and classical AYUSH-oriented wellness concepts to engineer standardized, evidence-backed formulations.
Partnership with Sheen Biotech Pvt. Ltd.
Sheen Biotech contributes advanced expertise in cannabinoid isolation, analytical chromatography, novel sublingual and transdermal drug delivery, and pharmaceutical quality assurance.
Structured 6-Stage Cannabinoid Model
Raw-Material Selection & Authentication
Legally sourced, fully traceable raw materials tested for botanical origin, purity, residual solvents, pesticides, and heavy metals.
Cannabinoid Profiling & Standardization
Consistent cannabinoid concentration (CBD, CBG, THCA), permitted THC limits where applicable, and strict batch-to-batch uniformity.
Molecular Synergy & Herbal Blending
Evaluating biological pathways and exploring rational combinations with synergistic Ayurvedic herbs (Ashwagandha, Shallaki, Brahmi).
Dosage-Form Development
Sublingual drops, tinctures, oral capsules, softgels, sprays, syrups, topical oils, and soothing dermal tubes.
Quality Assurance & Safety Evaluation
Identity, potency, stability, microbial safety, contaminant testing, packaging compatibility, and Certificate of Analysis (COA) generation.
Clinical & Regulatory Pathway
Operating under statutory licensing, institutional review boards, ethical protocols, and evidence-backed claims.
Cannabinoid Target Research Areas
Our collaborative research explores supportive care and quality-of-life interventions across high-need healthcare domains.
Oncology-Supportive Wellness
Researching supportive care for cancer patients regarding appetite stimulation, nausea relief, sleep stabilization, and restorative comfort.
Sleep Architecture & Disorders
Exploring non-habit-forming circadian alignment, rapid sleep latency, and reduction of nocturnal sleep disturbances.
Neurological & Epilepsy Support
Investigating neuro-protective pathways and nervous system stabilization under clinical supervision.
Stress & Mental Wellness
Targeting cortisol reduction, hypothalamic-pituitary-adrenal (HPA) axis balance, and cognitive relaxation.
Joint & Mobility Comfort
Topical and systemic cannabinoid formulations for chronic joint discomfort, cartilage ease, and physical flexibility.
Healthy Ageing & Neuro-Wellness
Supportive cellular protection and vitality for healthy neurological longevity.
